SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Justin K. Murray, Joseph Ligutti, Dong Liu, Anruo Zou, Leszek Poppe, Hongyan Li, Kristin L. Andrews, Bryan D. Moyer, Stefan I. McDonough, Philippe Favreau, Reto Stöcklin, Les P. Miranda, Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the NaV1.7 Sodium Channel, Journal of Medicinal Chemistry, 2015, 150219114219005

    CrossRef

  2. 2
    Danica Marković, Radmilo Janković, Ines Veselinović, Mutations in Sodium Channel Gene SCN9A and the Pain Perception Disorders, Advances in Anesthesiology, 2015, 2015, 1

    CrossRef

  3. 3
    Kathleen Yin, Katharina Zimmermann, Irina Vetter, Richard J. Lewis, Therapeutic opportunities for targeting cold pain pathways, Biochemical Pharmacology, 2015, 93, 2, 125

    CrossRef

  4. 4
    Vaskar Das, 2015,

    CrossRef

  5. 5
    Zamir Shorer, Einav Wajsbrot, Tamir-Hostovsky Liran, Jacov Levy, Ruti Parvari, A Novel Mutation in SCN9A in a Child With Congenital Insensitivity to Pain, Pediatric Neurology, 2014, 50, 1, 73

    CrossRef

  6. 6
    Maria Mansouri, Siham Chafai Elalaoui, Bouchra Ouled Amar Bencheikh, Mohamed El Alloussi, Patrick A. Dion, Abdelaziz Sefiani, Guy A. Rouleau, A Novel Nonsense Mutation in SCN9A in a Moroccan Child With Congenital Insensitivity to Pain, Pediatric Neurology, 2014, 51, 5, 741

    CrossRef

  7. 7
    F. Bartholomew, J. Lazar, A. Marqueling, C. Lee-Messer, S. Jaradeh, J. M. C. Teng, Channelopathy: a novel mutation in the SCN9A gene causes insensitivity to pain and autonomic dysregulation, British Journal of Dermatology, 2014, 171, 5
  8. 8
    Leema Reddy Peddareddygari, Kinsi Oberoi, Raji P. Grewal, Congenital Insensitivity to Pain: A Case Report and Review of the Literature, Case Reports in Neurological Medicine, 2014, 2014, 1

    CrossRef

  9. 9
    Shaoyi Sun, Charles J Cohen, Christoph M Dehnhardt, Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010, Pharmaceutical Patent Analyst, 2014, 3, 5, 509

    CrossRef

  10. 10
    Yigal Paul Goldberg, Charles J Cohen, Rostam Namdari, Nicola Price, Jay A Cadieux, Clint Young, Robin Sherrington, Simon Neil Pimstone, Letter to the Editor, Pain, 2014, 155, 4, 837

    CrossRef

  11. 11
    Dhiraj Kumar, Rashmi K. Ambasta, Pravir Kumar, Mutational Consequences of Aberrant Ion Channels in Neurological Disorders, The Journal of Membrane Biology, 2014, 247, 11, 1083

    CrossRef

  12. 12
    Michael S. Minett, Sarah Falk, Sonia Santana-Varela, Yury D. Bogdanov, Mohammed A. Nassar, Anne-Marie Heegaard, John N. Wood, Pain without Nociceptors? Nav1.7-Independent Pain Mechanisms, Cell Reports, 2014, 6, 2, 301

    CrossRef

  13. 13
    David L H Bennett, C Geoffrey Woods, Painful and painless channelopathies, The Lancet Neurology, 2014, 13, 6, 587

    CrossRef

  14. 14
    Brigitte A. Brouwer, Ingemar S. J. Merkies, Monique M. Gerrits, Stephen G. Waxman, Janneke G. J. Hoeijmakers, Catharina G. Faber, Painful neuropathies: the emerging role of sodium channelopathies, Journal of the Peripheral Nervous System, 2014, 19, 2
  15. 15
    Eslam Pourbasheer, Reza Aalizadeh, Mohammad Reza Ganjali, Parviz Norouzi, Javad Shadmanesh, Constantinos Methenitis, QSAR study of Nav1.7 antagonists by multiple linear regression method based on genetic algorithm (GA–MLR), Medicinal Chemistry Research, 2014, 23, 5, 2264

    CrossRef

  16. 16
    Arun P. Thottumkara, William H. Parsons, J. Du Bois, Saxitoxin, Angewandte Chemie, 2014, 126, 23
  17. 17
    Arun P. Thottumkara, William H. Parsons, J. Du Bois, Saxitoxin, Angewandte Chemie International Edition, 2014, 53, 23
  18. 18
    Stephen G Waxman, Ingemar S J Merkies, Monique M Gerrits, Sulayman D Dib-Hajj, Giuseppe Lauria, James J Cox, John N Wood, C Geoffrey Woods, Joost P H Drenth, Catharina G Faber, Sodium channel genes in pain-related disorders: phenotype–genotype associations and recommendations for clinical use, The Lancet Neurology, 2014, 13, 11, 1152

    CrossRef

  19. 19
    Yukiko Muroi, Bradley J. Undem, Targeting Voltage Gated Sodium Channels NaV1.7, NaV1.8, and NaV1.9 for Treatment of Pathological Cough, Lung, 2014, 192, 1, 15

    CrossRef

  20. 20
    Shaoyi Sun, Qi Jia, Alla Y. Zenova, Mikhail Chafeev, Zaihui Zhang, Sophia Lin, Rainbow Kwan, Mike E. Grimwood, Sultan Chowdhury, Clint Young, Charles J. Cohen, Renata M. Oballa, The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7, Bioorganic & Medicinal Chemistry Letters, 2014, 24, 18, 4397

    CrossRef

  21. 21
    Christopher Geoffrey Woods, Mohamed Osman Eltahir Babiker, Iain Horrocks, John Tolmie, Ingo Kurth, The phenotype of congenital insensitivity to pain due to the NaV1.9 variant p.L811P, European Journal of Human Genetics, 2014,

    CrossRef

  22. 22
    S. D. Dib-Hajj, S. G. Waxman, Translational pain research: Lessons from genetics and genomics, Science Translational Medicine, 2014, 6, 249, 249sr4

    CrossRef

  23. 23
    Mark Estacion, Yang Yang, Sulayman D. Dib-Hajj, Lynda Tyrrell, Zhimiao Lin, Yong Yang, Stephen G. Waxman, A new Nav1.7 mutation in an erythromelalgia patient, Biochemical and Biophysical Research Communications, 2013, 432, 1, 99

    CrossRef

  24. 24
    Scott B. Hoyt, Clare London, Catherine Abbadie, John P. Felix, Maria L. Garcia, Nina Jochnowitz, Bindhu V. Karanam, Xiaohua Li, Kathryn A. Lyons, Erin McGowan, Birgit T. Priest, McHardy M. Smith, Vivien A. Warren, Brande S. Thomas-Fowlkes, Gregory J. Kaczorowski, Joseph L. Duffy, A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain, Bioorganic & Medicinal Chemistry Letters, 2013, 23, 12, 3640

    CrossRef

  25. 25
    G. Borck, C. Kubisch, Ausgewählte Ionenkanalerkrankungen des peripheren Nervensystems, medizinische genetik, 2013, 25, 4, 448

    CrossRef

  26. 26
    S. Yang, Y. Xiao, D. Kang, J. Liu, Y. Li, E. A. B. Undheim, J. K. Klint, M. Rong, R. Lai, G. F. King, Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models, Proceedings of the National Academy of Sciences, 2013, 110, 43, 17534

    CrossRef

  27. 27
    Chun-Ping Huang, Hsiang-Ni Chen, Hong-Lin Su, Ching-Liang Hsieh, Wei-Hsin Chen, Zhen-Rung Lai, Yi-Wen Lin, Electroacupuncture Reduces Carrageenan- and CFA-Induced Inflammatory Pain Accompanied by Changing the Expression of Nav1.7 and Nav1.8, rather than Nav1.9, in Mice Dorsal Root Ganglia, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  28. 28
    Calvin Leung, Yana Wilson, Thang M Khuong, G Gregory Neely, Fruit flies as a powerful model to drive or validate pain genomics efforts, Pharmacogenomics, 2013, 14, 15, 1879

    CrossRef

  29. 29
    Shafaq Sikandar, Ryan Patel, Sital Patel, Sanam Sikander, David L.H. Bennett, Anthony H. Dickenson, Genes, molecules and patients—Emerging topics to guide clinical pain research, European Journal of Pharmacology, 2013, 716, 1-3, 188

    CrossRef

  30. 30
    Sharan K. Bagal, Alan D. Brown, Peter J. Cox, Kiyoyuki Omoto, Robert M. Owen, David C. Pryde, Benjamin Sidders, Sarah E. Skerratt, Edward B. Stevens, R. Ian Storer, Nigel A. Swain, Ion Channels as Therapeutic Targets: A Drug Discovery Perspective, Journal of Medicinal Chemistry, 2013, 56, 3, 593

    CrossRef

  31. 31
    Inna Belfer, Nature and Nurture of Human Pain, Scientifica, 2013, 2013, 1

    CrossRef

  32. 32
    Joel A Black, Janneke GJ Hoeijmakers, Catharina G Faber, Ingemar SJ Merkies, Stephen G Waxman, NaV1.7: Stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus, Molecular Pain, 2013, 9, 1, 39

    CrossRef

  33. 33
    Stephen G. Waxman, Painful Na-channelopathies: an expanding universe, Trends in Molecular Medicine, 2013, 19, 7, 406

    CrossRef

  34. 34
    Fan Zhang, Xunxun Xu, Tingting Li, Zhonghua Liu, Shellfish Toxins Targeting Voltage-Gated Sodium Channels, Marine Drugs, 2013, 11, 12, 4698

    CrossRef

  35. 35
    Sultan Chowdhury, Shifeng Liu, Jay A. Cadieux, Tom Hsieh, Mikhail Chafeev, Shaoyi Sun, Qi Jia, Jianyu Sun, Mark Wood, Jonathan Langille, Serguei Sviridov, Jianmin Fu, Zaihui Zhang, Ray Chui, Audrey Wang, Xing Cheng, Jing Zhong, Sazzad Hossain, Kuldip Khakh, Ivana Rajlic, Henry Verschoof, Rainbow Kwan, Wendy Young, Tetracyclic spirooxindole blockers of hNaV1.7: activity in vitro and in CFA-induced inflammatory pain model, Medicinal Chemistry Research, 2013, 22, 4, 1825

    CrossRef

  36. 36
    Michaela Auer-Grumbach, Peripheral Nerve Disorders, 2013,

    CrossRef

  37. 37
    Istvan Macsari, Yevgeni Besidski, Gabor Csjernyik, Linda I. Nilsson, Lars Sandberg, Ulrika Yngve, Kristofer Åhlin, Tjerk Bueters, Anders B. Eriksson, Per-Eric Lund, Elisabet Venyike, Sandra Oerther, Karin Hygge Blakeman, Lei Luo, Per I. Arvidsson, 3-Oxoisoindoline-1-carboxamides: Potent, State-Dependent Blockers of Voltage-Gated Sodium Channel NaV1.7 with Efficacy in Rat Pain Models, Journal of Medicinal Chemistry, 2012, 55, 15, 6866

    CrossRef

  38. 38
    Alan Ma, Anne Turner, A LIFE WITHOUT PAIN: CONGENITAL INSENSITIVITY TO PAIN DUE TO COMPOUND HETEROZYGOUS SCN9A MUTATION, Journal of Paediatrics and Child Health, 2012, 48, 3
  39. 39
    Ryoko Hirakawa, Nesrine El-Bizri, John C. Shryock, Luiz Belardinelli, Sridharan Rajamani, Block of Na+ currents and suppression of action potentials in embryonic rat dorsal root ganglion neurons by ranolazine, Neuropharmacology, 2012, 62, 7, 2251

    CrossRef

  40. 40
    Oliver Knapp, Jeffrey R. McArthur, David J. Adams, Conotoxins Targeting Neuronal Voltage-Gated Sodium Channel Subtypes: Potential Analgesics?, Toxins, 2012, 4, 12, 1236

    CrossRef

  41. 41
    Nagasree Chakka, Howie Bregman, Bingfan Du, Hanh Nho Nguyen, John L. Buchanan, Elma Feric, Joseph Ligutti, Dong Liu, Jeff S. McDermott, Anruo Zou, Stefan I. McDonough, Erin F. DiMauro, Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Nav1.7 antagonists, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 5, 2052

    CrossRef

  42. 42
    Hanh Nho Nguyen, Howie Bregman, John L. Buchanan, Bingfan Du, Elma Feric, Liyue Huang, Xingwen Li, Joseph Ligutti, Dong Liu, Annika B. Malmberg, David J. Matson, Jeff S. McDermott, Vinod F. Patel, Ben Wilenkin, Anruo Zou, Stefan I. McDonough, Erin F. DiMauro, Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonists, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 2, 1055

    CrossRef

  43. 43
    Joel A Black, Noémie Frézel, Sulayman D Dib-Hajj, Stephen G Waxman, Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn, Molecular Pain, 2012, 8, 1, 82

    CrossRef

  44. 44
    H. Houlden, Extending the clinical spectrum of pain channelopathies, Brain, 2012, 135, 2, 313

    CrossRef

  45. You have free access to this content45
    JGJ Hoeijmakers, ISJ Merkies, MM Gerrits, SG Waxman, CG Faber, Genetic aspects of sodium channelopathy in small fiber neuropathy, Clinical Genetics, 2012, 82, 4
  46. You have free access to this content46
    YP Goldberg, SN Pimstone, R Namdari, N Price, C Cohen, RP Sherrington, MR Hayden, Human Mendelian pain disorders: a key to discovery and validation of novel analgesics, Clinical Genetics, 2012, 82, 4
  47. 47
    HG Karstensen, N Tommerup, Isolated and syndromic forms of congenital anosmia, Clinical Genetics, 2012, 81, 3
  48. 48
    Darshani B. Rupasinghe, Oliver Knapp, Linda V. Blomster, Annina B. Schmid, David J. Adams, Glenn F. King, Marc J. Ruitenberg, Localization of Nav1.7 in the normal and injured rodent olfactory system indicates a critical role in olfaction, pheromone sensing and immune function, Channels, 2012, 6, 2, 103

    CrossRef

  49. 49
    Christelle Gaudioso, Jizhe Hao, Marie-France Martin-Eauclaire, Mélanie Gabriac, Patrick Delmas, Menthol pain relief through cumulative inactivation of voltage-gated sodium channels, Pain, 2012, 153, 2, 473

    CrossRef

  50. You have free access to this content50
    Y Indo, Nerve growth factor and the physiology of pain: lessons from congenital insensitivity to pain with anhidrosis, Clinical Genetics, 2012, 82, 4
  51. 51
    N. Eijkelkamp, J. E. Linley, M. D. Baker, M. S. Minett, R. Cregg, R. Werdehausen, F. Rugiero, J. N. Wood, Neurological perspectives on voltage-gated sodium channels, Brain, 2012, 135, 9, 2585

    CrossRef

  52. 52
    Ron Dabby, Pain Disorders and Erythromelalgia Caused by Voltage-Gated Sodium Channel Mutations, Current Neurology and Neuroscience Reports, 2012, 12, 1, 76

    CrossRef

  53. You have free access to this content53
    Stephen G. Waxman, Sodium channels, the electrogenisome and the electrogenistat: lessons and questions from the clinic, The Journal of Physiology, 2012, 590, 11
  54. 54
    Sulayman D. Dib-Hajj, Yang Yang, Joel A. Black, Stephen G. Waxman, The NaV1.7 sodium channel: from molecule to man, Nature Reviews Neuroscience, 2012, 14, 1, 49

    CrossRef

  55. 55
    Michael H. Ossipov, The Perception and Endogenous Modulation of Pain, Scientifica, 2012, 2012, 1

    CrossRef

  56. 56
    Yigal Paul Goldberg, Nicola Price, Rostam Namdari, Charles Jay Cohen, Mieke H. Lamers, Conrad Winters, James Price, Clint E. Young, Henry Verschoof, Robin Sherrington, Simon Neil Pimstone, Michael Reuben Hayden, Treatment of Nav1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker, Pain, 2012, 153, 1, 80

    CrossRef

  57. 57
    Stephen A. Smith, Robert Ouvrier, Swaiman's Pediatric Neurology, 2012,

    CrossRef

  58. 58
    Kelly Knupp, Julie A. Parsons, Amy R. Brooks-Kayal, Swaiman's Pediatric Neurology, 2012,

    CrossRef

  59. 59
    Jacqueline Panigel, Sean Peter Cook, A Point Mutation at F1737 of the Human Nav1.7 Sodium Channel Decreases Inhibition by Local Anesthetics, Journal of Neurogenetics, 2011, 25, 4, 134

    CrossRef

  60. 60
    Sultan Chowdhury, Mikhail Chafeev, Shifeng Liu, Jianyu Sun, Vandna Raina, Ray Chui, Wendy Young, Rainbow Kwan, Jianmin Fu, Jay A. Cadieux, Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain, Bioorganic & Medicinal Chemistry Letters, 2011, 21, 12, 3676

    CrossRef

  61. 61
    Claire Gaveriaux-Ruff, Chihiro Nozaki, Xavier Nadal, Xavier C. Hever, Raphael Weibel, Audrey Matifas, David Reiss, Dominique Filliol, Mohammed A. Nassar, John N. Wood, Rafael Maldonado, Brigitte L. Kieffer, Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia, Pain, 2011, 152, 6, 1238

    CrossRef

  62. 62
    Jörn Lötsch, Genetic variability of pain perception and treatment—clinical pharmacological implications, European Journal of Clinical Pharmacology, 2011, 67, 6, 541

    CrossRef

  63. 63
    Howard Bregman, Loren Berry, John L. Buchanan, April Chen, Bingfan Du, Elma Feric, Markus Hierl, Liyue Huang, David Immke, Brett Janosky, Danielle Johnson, Xingwen Li, Joseph Ligutti, Dong Liu, Annika Malmberg, David Matson, Jeff McDermott, Peter Miu, Hanh Nho Nguyen, Vinod F. Patel, Daniel Waldon, Ben Wilenkin, Xiao Mei Zheng, Anruo Zou, Stefan I. McDonough, Erin F. DiMauro, Identification of a Potent, State-Dependent Inhibitor of Nav1.7 with Oral Efficacy in the Formalin Model of Persistent Pain, Journal of Medicinal Chemistry, 2011, 54, 13, 4427

    CrossRef

  64. 64
    Jan Weiss, Martina Pyrski, Eric Jacobi, Bernd Bufe, Vivienne Willnecker, Bernhard Schick, Philippe Zizzari, Samuel J. Gossage, Charles A. Greer, Trese Leinders-Zufall, C. Geoffrey Woods, John N. Wood, Frank Zufall, Loss-of-function mutations in sodium channel Nav1.7 cause anosmia, Nature, 2011, 472, 7342, 186

    CrossRef

  65. 65
    Ronald G. Lafrenière, Guy A. Rouleau, Migraine: Role of the TRESK two-pore potassium channel, The International Journal of Biochemistry & Cell Biology, 2011, 43, 11, 1533

    CrossRef

  66. 66
    Stephen G. Waxman, Neuroscience: Channelopathies have many faces, Nature, 2011, 472, 7342, 173

    CrossRef

  67. 67
    Arjun Muralidharan, Maree T. Smith, Pain, analgesia and genetics, Journal of Pharmacy and Pharmacology, 2011, 63, 11
  68. 68
    Roland Staudl, Donald D. Pricel, David Janickel, Edgard Andradel, Angela G. Hadjipanayisl, Will T. Eatonl, Lee Kaplanl, Margaret R. Wallacel, Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain, European Journal of Pain, 2011, 15, 3
  69. 69
    Ruimei Yuan, Xianwei Zhang, Qian Deng, Dayong Si, Yuan Wu, Feng Gao, Biyun Zhou, Two Novel SCN9A Gene Heterozygous Mutations May Cause Partial Deletion of Pain Perception, Pain Medicine, 2011, 12, 10
  70. 70
    Allison T. Knoll, William A. Carlezon, Dynorphin, stress, and depression, Brain Research, 2010, 1314, 56

    CrossRef

  71. 71
    Tanya Z. Fischer, Stephen G. Waxman, Familial pain syndromes from mutations of the Nav1.7 sodium channel, Annals of the New York Academy of Sciences, 2010, 1184, 1
  72. 72
    Eduardo Gascon, Aziz Moqrich, Heterogeneity in primary nociceptive neurons: From molecules to pathology, Archives of Pharmacal Research, 2010, 33, 10, 1489

    CrossRef

  73. 73
    Elena Colombo, Simona Francisconi, Laura Faravelli, Emanuela Izzo, Paolo Pevarello, Ion channel blockers for the treatment of neuropathic pain, Future Medicinal Chemistry, 2010, 2, 5, 803

    CrossRef

  74. 74
    Steve England, David Rawson, Isoform-selective voltage-gated Na+channel modulators as next-generation analgesics, Future Medicinal Chemistry, 2010, 2, 5, 775

    CrossRef

  75. 75
    Dimitri M. Kullmann, Neurological Channelopathies, Annual Review of Neuroscience, 2010, 33, 1, 151

    CrossRef

  76. 76
    Ramin Raouf, Kathryn Quick, John N. Wood, Pain as a channelopathy, Journal of Clinical Investigation, 2010, 120, 11, 3745

    CrossRef

  77. 77
    F. Reimann, J. J. Cox, I. Belfer, L. Diatchenko, D. V. Zaykin, D. P. McHale, J. P. H. Drenth, F. Dai, J. Wheeler, F. Sanders, L. Wood, T.-X. Wu, J. Karppinen, L. Nikolajsen, M. Mannikko, M. B. Max, C. Kiselycznyk, M. Poddar, R. H. M. te Morsche, S. Smith, D. Gibson, A. Kelempisioti, W. Maixner, F. M. Gribble, C. G. Woods, Pain perception is altered by a nucleotide polymorphism in SCN9A, Proceedings of the National Academy of Sciences, 2010, 107, 11, 5148

    CrossRef

  78. 78
    Ruth Landau, Pharmacogenetic influences in obstetric anaesthesia, Best Practice & Research Clinical Obstetrics & Gynaecology, 2010, 24, 3, 277

    CrossRef

  79. 79
    Gregory P. Casey, Jomar S. Roberts, Dennis Paul, Ivan Diamond, Harry J. Gould III, Ranolazine Attenuation of CFA-induced Mechanical Hyperalgesia, Pain Medicine, 2010, 11, 1
  80. 80
    CN Doty, SCN9A: another sodium channel excited to play a role in human epilepsies, Clinical Genetics, 2010, 77, 4
  81. 81
    Georg C Terstappen, Renza Roncarati, John Dunlop, Ravikumar Peri, Screening technologies for ion channel drug discovery, Future Medicinal Chemistry, 2010, 2, 5, 715

    CrossRef

  82. 82
    Angelika Lampert, Andrias O. O’Reilly, Peter Reeh, Andreas Leffler, Sodium channelopathies and pain, Pflügers Archiv - European Journal of Physiology, 2010, 460, 2, 249

    CrossRef

  83. 83
    Sulayman D. Dib-Hajj, Theodore R. Cummins, Joel A. Black, Stephen G. Waxman, Sodium Channels in Normal and Pathological Pain, Annual Review of Neuroscience, 2010, 33, 1, 325

    CrossRef

  84. 84
    Natalie J. Saez, Sebastian Senff, Jonas E. Jensen, Sing Yan Er, Volker Herzig, Lachlan D. Rash, Glenn F. King, Spider-Venom Peptides as Therapeutics, Toxins, 2010, 2, 12, 2851

    CrossRef

  85. 85
    S.R.D.T. Siqueira, B. Alves, H.M.G. Malpartida, M.J. Teixeira, J.T.T. Siqueira, Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia, Neuroscience, 2009, 164, 2, 573

    CrossRef

  86. 86
    David Bowsher, Geoffrey C. Woods, Adeline K. Nicholas, Ofelia M. Carvalho, Carol E. Haggett, Brian Tedman, James M. Mackenzie, Daniel Crooks, Nasir Mahmood, Aidan J. Twomey, Samantha Hann, Dilwyn Jones, James P. Wymer, Phillip J. Albrecht, Charles E. Argoff, Frank L. Rice, Absence of pain with hyperhidrosis: A new syndrome where vascular afferents may mediate cutaneous sensation, Pain, 2009, 147, 1, 287

    CrossRef

  87. 87
    Irmgard Tegeder, Jörn Lötsch, Current evidence for a modulation of low back pain by human genetic variants, Journal of Cellular and Molecular Medicine, 2009, 13, 8b
  88. 88
    Angelika Lampert, Sulayman D. Dib-Hajj, Emmanuella M. Eastman, Lynda Tyrrell, Zhimiao Lin, Yong Yang, Stephen G. Waxman, Erythromelalgia mutation L823R shifts activation and inactivation of threshold sodium channel Nav1.7 to hyperpolarized potentials, Biochemical and Biophysical Research Communications, 2009, 390, 2, 319

    CrossRef

  89. 89
    Jörn Lötsch, Gerd Geisslinger, Irmgard Tegeder, Genetic modulation of the pharmacological treatment of pain, Pharmacology & Therapeutics, 2009, 124, 2, 168

    CrossRef

  90. 90
    N. Danziger, J.-C. Willer, L’insensibilité congénitale à la douleur, Revue Neurologique, 2009, 165, 2, 129

    CrossRef

  91. 91
    Jin-Sung Choi, Lili Zhang, Sulayman D. Dib-Hajj, Chongyang Han, Lynda Tyrrell, Zhimiao Lin, Xiaoliang Wang, Yong Yang, Stephen G. Waxman, Mexiletine-responsive erythromelalgia due to a new Nav1.7 mutation showing use-dependent current fall-off, Experimental Neurology, 2009, 216, 2, 383

    CrossRef

  92. 92
    Michael L. LaCroix-Fralish, Jeffrey S. Mogil, Progress in Genetic Studies of Pain and Analgesia, Annual Review of Pharmacology and Toxicology, 2009, 49, 1, 97

    CrossRef

  93. 93
    Harry J. Gould, Colleen Garrett, Renee R. Donahue, Dennis Paul, Ivan Diamond, Bradley K. Taylor, Ranolazine attenuates behavioral signs of neuropathic pain, Behavioural Pharmacology, 2009, 20, 8, 755

    CrossRef

  94. 94
    Anindya Bhattacharya, Alan D. Wickenden, Sandra R. Chaplan, Sodium channel blockers for the treatment of neuropathic pain, Neurotherapeutics, 2009, 6, 4, 663

    CrossRef

  95. 95
    Steve England, Marcel J de Groot, Subtype-selective targeting of voltage-gated sodium channels, British Journal of Pharmacology, 2009, 158, 6
  96. 96
    P. L. Tan, N. Katsanis, Thermosensory and mechanosensory perception in human genetic disease, Human Molecular Genetics, 2009, 18, R2, R146

    CrossRef

  97. 97
    Neelima Khairatkar-Joshi, Arpad Szallasi, TRPV1 antagonists: the challenges for therapeutic targeting, Trends in Molecular Medicine, 2009, 15, 1, 14

    CrossRef

  98. 98
    K. B. Nilsen, A. K. Nicholas, C. G. Woods, S. I. Mellgren, M. Nebuchennykh, J. Aasly, Two novel SCN9A mutations causing insensitivity to pain, Pain, 2009, 143, 1, 155

    CrossRef

  99. 99
    Sulayman D. Dib-Hajj, Alexander M. Binshtok, Theodore R. Cummins, Michael F. Jarvis, Tarek Samad, Katharina Zimmermann, Voltage-gated sodium channels in pain states: Role in pathophysiology and targets for treatment, Brain Research Reviews, 2009, 60, 1, 65

    CrossRef

  100. You have free access to this content100
    Sulayman D. Dib-Hajj, Joel A. Black, Stephen G. Waxman, Voltage-Gated Sodium Channels: Therapeutic Targets for Pain, Pain Medicine, 2009, 10, 7
  101. 101
    André Tadić, Ömur Baskaya, Anja Victor, Klaus Lieb, Wolfgang Höppner, Norbert Dahmen, Association analysis of SCN9A gene variants with borderline personality disorder, Journal of Psychiatric Research, 2008, 43, 2, 155

    CrossRef

  102. 102
    D. C. De Andrade, S. Baudic, N. Attal, C. L. Rodrigues, P. Caramelli, A. M. M. Lino, P. E. Marchiori, M. Okada, M. Scaff, D. Bouhassira, M. J. Teixeira, Beyond neuropathy in hereditary sensory and autonomic neuropathy type V: cognitive evaluation, European Journal of Neurology, 2008, 15, 7
  103. 103
    Sang Jin Choi, Tae Hoon Kim, Yong Kyoo Shin, Chung Soo Lee, Mijung Park, Hyun Sun Lee, Jin-Ho Song, Effects of a polyacetylene from Panax ginseng on Na+ currents in rat dorsal root ganglion neurons, Brain Research, 2008, 1191, 75

    CrossRef

  104. 104
    Jeong Seon Cho, Tae Hoon Kim, Jae-Min Lim, Jin-Ho Song, Effects of eugenol on Na+ currents in rat dorsal root ganglion neurons, Brain Research, 2008, 1243, 53

    CrossRef

  105. 105
    Bruno Oertel, Jörn Lötsch, Genetic mutations that prevent pain: implications for future pain medication, Pharmacogenomics, 2008, 9, 2, 179

    CrossRef

  106. 106
    James K.J. Diss, Mattia Calissano, Duncan Gascoyne, Mustafa B.A. Djamgoz, David S. Latchman, Identification and characterization of the promoter region of the Nav1.7 voltage-gated sodium channel gene (SCN9A), Molecular and Cellular Neuroscience, 2008, 37, 3, 537

    CrossRef

  107. 107
    Clare London, Scott B. Hoyt, William H. Parsons, Brande S. Williams, Vivien A. Warren, Richard Tschirret-Guth, McHardy M. Smith, Birgit T. Priest, Erin McGowan, William J. Martin, Kathryn A. Lyons, Xiaohua Li, Bindhu V. Karanam, Nina Jochnowitz, Maria L. Garcia, John P. Felix, Brian Dean, Catherine Abbadie, Gregory J. Kaczorowski, Joseph L. Duffy, Imidazopyridines: A novel class of hNav1.7 channel blockers, Bioorganic & Medicinal Chemistry Letters, 2008, 18, 5, 1696

    CrossRef

  108. 108
    Siew M. Keh, Paul Facer, Karen D. Simpson, Guri Sandhu, Hesham A. Saleh, Praveen Anand, Increased Nerve Fiber Expression of Sensory Sodium Channels Nav1.7, Nav1.8, and Nav1.9 in Rhinitis, The Laryngoscope, 2008, 118, 4
  109. 109
    Joel A. Black, Lone Nikolajsen, Karsten Kroner, Troels S. Jensen, Stephen G. Waxman, Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas, Annals of Neurology, 2008, 64, 6
  110. 110
    N.C.H. Kerr, F.E. Holmes, D. Wynick, Novel mRNA isoforms of the sodium channels Nav1.2, Nav1.3 and Nav1.7 encode predicted two-domain, truncated proteins, Neuroscience, 2008, 155, 3, 797

    CrossRef

  111. 111
    Ruth Landau, Pharmacogenetics and Obstetric Anesthesia, Anesthesiology Clinics, 2008, 26, 1, 183

    CrossRef

  112. 112
    Aliakmal Momin, John N Wood, Sensory neuron voltage-gated sodium channels as analgesic drug targets, Current Opinion in Neurobiology, 2008, 18, 4, 383

    CrossRef

  113. 113
    John David Clark, The Pitfalls of Profoundly Effective Analgesic Therapies, The Clinical Journal of Pain, 2008, 24, 9, 825

    CrossRef

  114. 114
    Steve England, Voltage-gated sodium channels: the search for subtype-selective analgesics, Expert Opinion on Investigational Drugs, 2008, 17, 12, 1849

    CrossRef

  115. 115
    Sulayman D. Dib-Hajj, Yong Yang, Stephen G. Waxman, 2008,

    CrossRef

  116. 116
    Scott B. Hoyt, Clare London, Hyun Ok, Edward Gonzalez, Joseph L. Duffy, Catherine Abbadie, Brian Dean, John P. Felix, Maria L. Garcia, Nina Jochnowitz, Bindhu V. Karanam, Xiaohua Li, Kathryn A. Lyons, Erin McGowan, D. Euan MacIntyre, William J. Martin, Birgit T. Priest, McHardy M. Smith, Richard Tschirret-Guth, Vivien A. Warren, Brande S. Williams, Gregory J. Kaczorowski, William H. Parsons, Benzazepinone Nav1.7 blockers: Potential treatments for neuropathic pain, Bioorganic & Medicinal Chemistry Letters, 2007, 17, 22, 6172

    CrossRef

  117. 117
    Scott B. Hoyt, Clare London, David Gorin, Matthew J. Wyvratt, Michael H. Fisher, Catherine Abbadie, John P. Felix, Maria L. Garcia, Xiaohua Li, Kathryn A. Lyons, Erin McGowan, D. Euan MacIntyre, William J. Martin, Birgit T. Priest, Amy Ritter, McHardy M. Smith, Vivien A. Warren, Brande S. Williams, Gregory J. Kaczorowski, William H. Parsons, Discovery of a novel class of benzazepinone Nav1.7 blockers: Potential treatments for neuropathic pain, Bioorganic & Medicinal Chemistry Letters, 2007, 17, 16, 4630

    CrossRef

  118. 118
    Sulayman D. Dib-Hajj, Theodore R. Cummins, Joel A. Black, Stephen G. Waxman, From genes to pain: Nav1.7 and human pain disorders, Trends in Neurosciences, 2007, 30, 11, 555

    CrossRef

  119. 119
    Luda Diatchenko, Andrea G. Nackley, Inna E. Tchivileva, Svetlana A. Shabalina, William Maixner, Genetic architecture of human pain perception, Trends in Genetics, 2007, 23, 12, 605

    CrossRef

  120. 120
    Clifford J. Woolf, Qiufu Ma, Nociceptors—Noxious Stimulus Detectors, Neuron, 2007, 55, 3, 353

    CrossRef

  121. 121
    Theodore R. Cummins, Patrick L. Sheets, Stephen G. Waxman, The roles of sodium channels in nociception: Implications for mechanisms of pain, Pain, 2007, 131, 3, 243

    CrossRef

  122. 122
    Theodore R Cummins, Anthony M Rush, Voltage-gated sodium channel blockers for the treatment of neuropathic pain, Expert Review of Neurotherapeutics, 2007, 7, 11, 1597

    CrossRef

  123. 123
    Joshua S. Wingerd, Irina Vetter, Richard J. Lewis, Voltage-Gated Sodium Channels as Therapeutic Targets,